- Shares of MannKind Corp. (MNKD) are down 18% before the open on mediocre volume in response to the FDA extending its AFREZZA PDUFA date three months to July 15.
- The company says the agency needs the time to review the information it submitted in response to its requests.
- This should not be surprising since the Ad Comm meeting was only a week ago.
From other sites
at Nasdaq.com (Apr 9, 2015)
Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releasesat Zacks.com (Mar 18, 2015)
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Feb 25, 2015)
at Zacks.com (Feb 25, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs